• Hero Banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Buying or Selling a Practice
Hospital Design
Leadership & Personal Growth
Personnel Management
Practice Finances
Practice Operations
Technology
Wellbeing & Lifestyle
Continuing Education
Conferences
Live Conferences
Conference News
Conference Proceedings
Resources
CBD in Pets
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

15-mg phenobarbital tablets recalled; pills are actually 30 mg each

May 13, 2017

Labeling error leads to product withdrawal due to potential for patient harm.

This article has been updated to reflect an expansion of the original recall.

C.O. Truxton Inc. has expanded a recall of phenobarbital that began with a label mixup affecting tablets labeled 15 mg. Those pills were discovered to be 30 mg, which could have led to overdosing of people and pets receiving the medication, according to a release from the U.S. Food and Drug Administration (FDA).

In late April the company voluntarily recalled lot 70952A, which contained at least one bottle of 30-mg phenobarbital tablets labeled as 15 mg, but several weeks later it expanded the recall to cover multiple lots of 15-mg, 30-mg, 60-mg and 100-mg phenobarbital tablets, as well as one lot of 50-mg amitriptylene tablets. C.O. Truxton has not received any complaints related to products included in the expanded recall but is exercising “an abundance of caution,” the FDA states.

The mislabeled product could expose people or pets to potential overdosing that can cause severe intoxication leading to cardiogenic shock, renal failure, coma or death, although the manufacturer has not received any reports of adverse events, the FDA states.

Advertisement

Phenobarbital is indicated for use as a sedative or anticonvulsant and is packaged in 1,000-count bottles. The 15-mg tablet is debossed with “West-ward 445” on one side and blank on the reverse side; the 30-mg tablet is debossed with “West-ward 450” on one side and scored on the reverse side. The product was distributed nationwide to physicians and veterinarians, the release states.

C.O. Truxton is notifying all customers on record who purchased affected product by U.S. mail, and the company is arranging for full-credit returns or replacements of recalled product. Anyone who possesses recalled product should stop using the product and return it to the place of purchase.

Veterinarians and pet owners with questions can contact C.O Truxton at (856) 933-2333.

Related Content:

RecallsNeurologyBreaking News
The new Shreiber School of Veterinary Medicine breaks ground
The new Shreiber School of Veterinary Medicine breaks ground
A veterinary neurologist’s clinical approach to epilepsy
A veterinary neurologist’s clinical approach to epilepsy
Fentanyl combined with xylazine designated an emerging threat to the United States
Fentanyl combined with xylazine designated an emerging threat to the United States

Advertisement

Latest News

Morris Animal Foundation announces fellowships

Zoetis announces Apoquel grant program

American Veterinary Medical Foundation welcomes new executive director

Details of new pet performance supplement line revealed

View More Latest News
Advertisement